These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16377304)

  • 1. "Improvement" in the placebo group could be due to regression to the mean as well as to sociobiologic factors.
    Rück A; Sylvén C
    Am J Cardiol; 2006 Jan; 97(1):152-3. PubMed ID: 16377304
    [No Abstract]   [Full Text] [Related]  

  • 2. [Roaming through methodology. XVII. The placebo effect].
    de Craen AJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):322-4. PubMed ID: 10707743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression to the mean: treatment effect without the intervention.
    Morton V; Torgerson DJ
    J Eval Clin Pract; 2005 Feb; 11(1):59-65. PubMed ID: 15660538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistics and the relationship of clinical research to clinical practice.
    Khuder SA; Kahaleh B
    J Rheumatol; 2009 Feb; 36(2):219-20. PubMed ID: 19208555
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of database controls in pilot or futility studies in ALS.
    Czaplinski A; Haverkamp LJ; Yen AA; Simpson EP; Lai EC; Appel SH
    Neurology; 2006 Nov; 67(10):1827-32. PubMed ID: 17130417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials and the response rate illusion.
    Kirsch I; Moncrieff J
    Contemp Clin Trials; 2007 Jul; 28(4):348-51. PubMed ID: 17182286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Placebo, placebo effect and clinical trials].
    de la Fuente-Fernández R
    Neurologia; 2007 Mar; 22(2):69-71. PubMed ID: 17323230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged Lyme disease treatment: enough is enough.
    Halperin JJ
    Neurology; 2008 Mar; 70(13):986-7. PubMed ID: 17928578
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-placebo difference: in antidepressant drug trials could be 50% greater than previously believed.
    Rihmer Z
    Neuropsychopharmacol Hung; 2007 Mar; 9(1):35-7. PubMed ID: 17879563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo effect-adjusted assessment of quality of life in placebo-controlled clinical trials.
    Eickhoff JC
    Stat Med; 2008 Apr; 27(9):1387-402. PubMed ID: 18219702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling placebo response in depression trials using a longitudinal model with informative dropout.
    Gomeni R; Lavergne A; Merlo-Pich E
    Eur J Pharm Sci; 2009 Jan; 36(1):4-10. PubMed ID: 19041717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture for low back pain: interpretive leaps of faith. Re: Yuan J, Purepong N, Kerr DP, et al. Effectiveness of acupuncture for low back pain. A systematic review. Spine 2008;33:23:E887-900.
    O'Connell NE; Wand BM; Bausell RB
    Spine (Phila Pa 1976); 2009 Apr; 34(7):752; author reply 753. PubMed ID: 19333116
    [No Abstract]   [Full Text] [Related]  

  • 14. Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis.
    Zhao Y; Traboulsee A; Petkau AJ; Li D
    Neurology; 2008 Mar; 70(13 Pt 2):1092-7. PubMed ID: 18003938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using disease progression models as a tool to detect drug effect.
    Mould DR; Denman NG; Duffull S
    Clin Pharmacol Ther; 2007 Jul; 82(1):81-6. PubMed ID: 17507925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the placebo response in antidepressant trials.
    Rief W; Nestoriuc Y; Weiss S; Welzel E; Barsky AJ; Hofmann SG
    J Affect Disord; 2009 Nov; 118(1-3):1-8. PubMed ID: 19246102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Levin BJ; Thompson G; Mitsumoto LH; Kaufmann P
    Neurology; 2006 Jun; 66(11):1786-7; author reply 1786-7. PubMed ID: 16769973
    [No Abstract]   [Full Text] [Related]  

  • 18. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of placebo analgesia: Effect of dispositional optimism.
    Morton DL; Watson A; El-Deredy W; Jones AK
    Pain; 2009 Nov; 146(1-2):194-8. PubMed ID: 19692178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial methodology and patient characteristics did not influence the size of placebo effects on pain.
    Kamper SJ; Machado LA; Herbert RD; Maher CG; McAuley JH
    J Clin Epidemiol; 2008 Mar; 61(3):256-60. PubMed ID: 18226748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.